Skip to main content
RESMED INC logo

RESMED INC — Investor Relations & Filings

Ticker · RMD LEI · 254900O2VD7IQ5OGI615 ASX Manufacturing
Open in API
Filings indexed 1,643 across all filing types
Latest filing 2011-02-24 Director's Dealing
Country AU Australia
Listing ASX RMD

About RESMED INC

https://www.resmed.com

ResMed Inc. is a global leader in the development, manufacturing, and distribution of medical devices and cloud-based software solutions for the management of sleep-disordered breathing, chronic obstructive pulmonary disease, and other respiratory conditions. The company’s primary product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel machines, and a variety of masks and accessories designed to improve patient adherence and comfort. ResMed distinguishes itself through its focus on digital health, offering integrated software platforms that enable remote patient monitoring and data-driven clinical insights for healthcare providers. Additionally, the company provides software-as-a-service (SaaS) solutions to support out-of-hospital care settings, including home health, hospice, and skilled nursing facilities, aiming to improve patient outcomes and reduce overall healthcare costs.

Recent filings

Filing Released Lang Actions
Change of Director`s Interest Notice 3 pages 37.2KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and details changes in securities holdings by a company director, including the number of securities held before and after the change, the nature of the change, and transaction details. It references ASX listing rules and the Corporations Act, indicating it is a regulatory disclosure related to insider trading or director share transactions. The content is focused on personal share transactions by a director rather than company-wide financial results or governance changes. This matches the definition of 'Director's Dealing' filings, which report personal share transactions by company directors and executives (insider trades). The document length is 3702 characters, which is consistent with a detailed notice but not a full financial report. Therefore, the correct classification is DIRS.
2011-02-24 English
Change of Director`s Interest Notice 3 pages 37.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a director, including the number of securities held before and after the change, the nature of the change (on-market trade), and the value of the transaction. There is no financial performance data, earnings information, or report content. The document is a formal notification of a director's personal share transactions, which fits the definition of Director's Dealing filings.
2011-02-23 English
Response to ASX query on Appendix 3Z 3 pages 439.5KB
Regulatory Filings Classification · 95% confidence The document is a letter from ASX Compliance Pty Limited to ResMed Inc regarding a late filing of Appendix 3Z, which is a Final Director's Interest Notice. The letter references listing rules 3.19A and 3.19B concerning directors' disclosure obligations and requests explanations and compliance measures. The content focuses on regulatory compliance and director disclosures rather than financial results, management changes, or other report types. It is not a financial report, earnings release, or management report. It is a regulatory compliance inquiry related to director's dealings and disclosures. Therefore, the document fits best under Regulatory Filings (RNS) as it is a regulatory announcement and compliance communication that does not fit other specific categories.
2011-02-23 English
Daily share buy-back notice - Appendix 3E 2 pages 55.6KB
Transaction in Own Shares Classification · 100% confidence The document is titled 'Appendix 3E' and is a 'Daily share buy-back notice' related to on-market share repurchases by ResMed Inc. It provides details on the number of shares bought back, total consideration paid, and compliance statements. The document is short (2216 characters) and focuses on reporting share repurchase activity rather than a full financial report or announcement of a report. This matches the description of a 'Transaction in Own Shares' filing, which reports company buyback activities. Therefore, the correct classification is POS (Transaction in Own Shares).
2011-02-14 English
Credit Agreement 4 pages 89.4KB
Capital/Financing Update Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated February 10, 2011, by ResMed Inc. It reports the entry into a material definitive agreement, specifically a $300 million revolving credit facility with detailed terms and conditions. The content focuses on financing arrangements, credit agreements, and related covenants. There are no financial statements or earnings data presented, nor is it an announcement of a report publication. The primary subject is a financing update regarding the company's credit facility. Therefore, the document fits the category of Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing agreement, supporting a high confidence classification.
2011-02-14 English
Amended Credit Agreement 154 pages 418.8KB
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K current report filed by ResMed Inc. on February 14, 2011, reporting an event dated February 10, 2011. The content describes the entry into a material definitive agreement, specifically a Credit Agreement for a revolving credit facility of $300 million. The document includes detailed terms of the credit facility, covenants, conditions, and exhibits such as the Credit Agreement itself and related security agreements. There is no indication that this is a full annual or quarterly report, earnings release, or other financial statement. Instead, it is a regulatory filing reporting a financing event and the creation of a direct financial obligation. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length and detail confirm it is the actual agreement and not just an announcement or summary, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS) fallback. Therefore, the appropriate classification is CAP with high confidence.
2011-02-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.